Kaiser Permanente Northwest-Central Interstate--Oncology (Site 2816)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Closed trials

• Completed

  Study of Pembrolizumab/Vibostolimab (MK-7684A) in Combination With Concurrent Chemoradiotherapy Followed by Pembrolizumab/Vibostolimab Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Stage III Non-small Cell Lung Cancer (MK-7684A-006)

  NCT05298423· Phase 3· Merck Sharp & Dohme LLC· Source